Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer

Lung cancer is the leading cause of cancer‐associated death, and non‐small cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases. Many drugs have been used to treat NSCLC in order to improve patient prognosis. Platinum‐based chemotherapy is the first‐line treatment for locally advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Leirong, Ma, Leina, Xu, Fei, Zhai, Wenxin, Dong, Shenghua, Yin, Ling, Liu, Jia, Yu, Zhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Mini Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026617/
https://www.ncbi.nlm.nih.gov/pubmed/29726094
http://dx.doi.org/10.1111/1759-7714.12652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026617/
https://www.ncbi.nlm.nih.gov/pubmed/29726094
http://dx.doi.org/10.1111/1759-7714.12652

Ejemplares similares